These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33065776)

  • 21. BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment.
    Geisler CH; Hansen MM; Andersen NS; Brown P; Christensen LD; Dickmeiss E; Ersbøll J; Myhre J; Hansen M; Juhl BR; Mortensen BT; Pedersen-Bjergaard J
    Eur J Haematol; 1998 Sep; 61(3):173-82. PubMed ID: 9753413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation.
    Arboe B; Halgren Olsen M; Duun-Henriksen AK; Gørløv JS; Nielsen KF; Thomsen RH; Madsen C; Nielsen SR; Dalton SO; Brown PN
    Leuk Lymphoma; 2018 May; 59(5):1153-1162. PubMed ID: 28868963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The additional use of viral entry inhibitors during autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma and HIV-1 infection.
    Hütter G; Allers K; Schneider T
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):586-7. PubMed ID: 19892025
    [No Abstract]   [Full Text] [Related]  

  • 25. [Non Hodgkin lymphoma during pregnancy].
    Wiecheć M; Kempf Haber M; Załuska A; Klimek M; Skotnicki AB
    Ginekol Pol; 2005 Feb; 76(2):135-40. PubMed ID: 15847081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
    J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients.
    Visani G; Malerba L; Stefani PM; Capria S; Galieni P; Gaudio F; Specchia G; Meloni G; Gherlinzoni F; Giardini C; Falcioni S; Cuberli F; Gobbi M; Sarina B; Santoro A; Ferrara F; Rocchi M; Ocio EM; Caballero MD; Isidori A
    Blood; 2011 Sep; 118(12):3419-25. PubMed ID: 21816830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.
    Kumar L; Ganessan P; Ghosh I; Panda D; Gogia A; Mandhania S
    Natl Med J India; 2010; 23(6):330-5. PubMed ID: 21561042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.
    Capria S; Barberi W; Perrone S; Ferretti A; Salaroli A; Annechini G; D'Elia GM; Foà R; Pulsoni A
    Expert Rev Hematol; 2016 Oct; 9(10):951-64. PubMed ID: 27539362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
    Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
    Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose chemotherapy with thiotepa, mitoxantrone and carboplatin (TMJ) followed by autologous stem cell support in 100 consecutive lymphoma patients in a single centre: analysis of efficacy, toxicity and prognostic factors.
    Waheed F; Kancherla R; Seiter K; Liu D; Qureshi Z; Hoang A; Ahmed T
    Leuk Lymphoma; 2004 Nov; 45(11):2253-9. PubMed ID: 15512814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autologous transplant with BEAM protocol in lymphoma].
    Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
    Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement.
    Qualls D; Sullivan A; Li S; Brunner AM; Collier K; Hochberg E; Armand P; Batchelor TT; Chen YB; DeFilipp Z
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):884-888. PubMed ID: 28870642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous hematopoietic stem cell transplant in a patient with leprosy: Is it safe?
    Salomão MC; Batista MV; de Macedo MC; Sotto MN; Duarte AN; Rocha VG; Higashino HR; Costa SF
    Transpl Infect Dis; 2018 Apr; 20(2):e12840. PubMed ID: 29359841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell transplantation for indolent lymphoma.
    Krackhardt A; Gribben JG
    Curr Opin Hematol; 1999 Nov; 6(6):388-93. PubMed ID: 10546792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the role of autologous transplant for lymphoma in the current era?
    Stiff P
    Hematology Am Soc Hematol Educ Program; 2015; 2015():74-81. PubMed ID: 26637704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tandem high-dose therapy followed by autologous stem-cell transplantation for refractory or relapsed high grade non-Hodgkin's lymphoma with poor prognosis factors: a prospective pilot study.
    Le Gouill S; Moreau P; Morineau N; Harousseau JL; Milpied N
    Haematologica; 2002 Mar; 87(3):333-4. PubMed ID: 11869953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
    Flowers CR; Costa LJ; Pasquini MC; Le-Rademacher J; Lill M; Shore TB; Vaughan W; Craig M; Freytes CO; Shea TC; Horwitz ME; Fay JW; Mineishi S; Rondelli D; Mason J; Braunschweig I; Ai W; Yeh RF; Rodriguez TE; Flinn I; Comeau T; Yeager AM; Pulsipher MA; Bence-Bruckler I; Laneuville P; Bierman P; Chen AI; Kato K; Wang Y; Xu C; Smith AJ; Waller EK
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1197-1205. PubMed ID: 27040394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation.
    Villa D; Crump M; Keating A; Panzarella T; Feng B; Kuruvilla J
    Ann Oncol; 2013 Jun; 24(6):1603-9. PubMed ID: 23425946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.